Chronic Graft Versus Host Disease clinical trials in Florida
9 active Chronic Graft Versus Host Disease trials with a site in Florida. Describe your situation to see which ones look like a fit.
- Phase I/II Study of Pacritinib, A JAK2/IRAK1/CSF1R Inhibitor, in Refractory Chronic Graft-Versus-Host Disease (cGVHD) After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
- A Study of Axatilimab at 3 Different Doses in Participants With Chronic Graft Versus Host Disease (cGVHD)
- Axatilimab for Sclerotic Chronic Graft-versus-Host Disease
- Axatilimab in Combination With Extracorporeal Photopheresis (ECP) in Chronic Graft-versus-Host Disease
- A Study to Evaluate Vimseltinib in Adults With Active Chronic Graft-Versus-Host Disease (cGVHD)
- Belumosudil for the Pre-emptive Treatment of Patients With Chronic Graft Versus Host Disease
- Ruxolitinib vs Prednisone as First-line Therapy for cGVHD Needing Systemic Therapy
- Observational Study for Patients at Risk for Chronic Graft-Versus-Host Disease
- Predicting the Quality of Response to Specific Treatments in Patients With cGVHD, PQRST Study
Guides for people searching for a trial
- How to search for a trial without losing your mindWhere to look, what to gather first, and how to read what you find.
- Why people get turned down — and what to do nextWhat eligibility criteria are for, what keeps people out, and where to go when the first door closes.
- How your biomarkers decide which trials you qualify forEGFR, HER2, BRAF, PD-L1 and the rest — what they are and why they increasingly gate access.
- What Phase 1, 2 and 3 actually mean for youWhat each phase is testing, and how to weigh an early-phase trial against a later one.
- 10 questions to ask before you say yesTreatment, time, cost, safety and your rights. Worth bringing to a screening visit.
- You matched with a trial. What happens now?Phone screens, the screening visit, informed consent, and day one.